Mortality Highest for Asians, Hispanic/Latinos With Lupus
FRIDAY, Feb. 19, 2021 -- Standardized mortality ratios (SMRs) of observed-to-expected deaths are increased for patients with systemic lupus erythematosus (SLE) and are especially high for Asians and Hispanic/Latinos, according to research published in the Feb. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Milena A. Gianfrancesco, Ph.D., from the University of California in San Francisco, and colleagues examined the risk for SLE and population-based estimates of mortality by race and ethnicity using data from 812 patients in the California Lupus Surveillance Project (CLSP) during 2007 to 2009, who were matched to the 2007 to 2017 National Death Index.
The researchers found that 16.6 percent of the patients from the CLSP had died by 2017, including 14.4, 25, 15.3, and 15.5 percent of patients of White, Black, Asian, and Hispanic/Latino race/ethnicity, respectively. For each racial/ethnic group, the corresponding SMRs of observed-to-expected deaths among persons with SLE were 2.3, 2.0, 3.8, and 3.9. SMRs were especially higher among Asian and Hispanic/Latina women with SLE (4.1 and 5.8, respectively).
"Mortality among persons with SLE is high among all racial and ethnic groups but is especially pronounced in Asian and Hispanic/Latino populations," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, Jan. 21, 2021 -- The estimated prevalence of systemic lupus erythematosus (SLE) in the United States is 72.8/100,000, according to a study published online Jan. 21 in...
MONDAY, Jan. 11, 2021 -- For patients with systemic lupus erythematosus (SLE), lower hydroxychloroquine (HCQ) blood levels are associated with a higher risk for thrombotic events,...
WEDNESDAY, Jan. 6, 2021 -- Two-thirds of people with lupus are willing to receive a COVID-19 vaccine, according to the results of a survey released by the Lupus Research...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.